Health Care
Commentary
Learn more about how government intervention is harming the healthcare market
Trump vs. Harris on Health Care: Experts Explain Each Side
“He and his colleagues believe that patients are not in control of the health care system and that we suffer from an opaque and complex pricing structure that harms patients. “Winegarden’s free market approach means he advocates for doing away with the Obamacare subsidies that Congress must consider, as they ...
Commentary
Learn more about how price controls hurt patients
Harris’s Home Care Promises Unworkable, Unwise
U.S. Vice President Kamala Harris’s new proposal to provide subsidized at-home care for seniors through Medicare has received a warm reception from many academics and advocates for the elderly. But the likely cost of this new plan — not just to taxpayers but to the health of patients both present and future ...
Commentary
Learn more about escalating healthcare costs
Medicare should not cover at-home care
Vice President Kamala Harris announced a plan earlier this month to add home healthcare benefits to Medicare. The plan is a fiscal fantasy. Medicare is already in a fiscal crisis, and new benefits will only make things worse. According to the Brookings Institution, covering seniors’ home care for even one year would cost Medicare $40 billion. The program ...
Commentary
Learn more about health care reform
What Trump’s health care plan could look like
Former President Donald Trump has been jeered for saying he has “concepts of a plan” for repealing and replacing Obamacare. But that’s not quite fair. Trump’s first term in office suggests that he favors market-based reforms that increase patients’ choices. With just under a month until the election, it’s time ...
Commentary
Learn more about how price fixing stifles innovation
New Schizophrenia Drug Represents Promise Of Pharmaceutical Innovation
Late last month, the U.S. Food and Drug Administration approved Bristol Myers Squibb’s KarXT, a treatment for schizophrenia. The drug, which will be marketed under the brand name Cobenfy, is promising not just because it is effective at treating the debilitating mental health condition. It also seems not to have the potentially harmful side ...
Commentary
Learn more about healthcare reform
Vance’s Critics Wrong: No Need to Fear High-Risk Pools
Following the recent vice-presidential debate, Sen. J.D. Vance, R-Ohio, continues to face attacks on his ideas for covering people with pre-existing conditions. Vance’s critics call his proposal — which would separate out sicker patients into a separate high-risk insurance pool — inhumane and impractical. As Arthur Caplan, the head of medical ethics at NYU ...
Commentary
Learn more about how price controls are driving physician shortages
Price Controls Are Harming Doctors
Whether its pharmaceuticals or health insurance, Vice President Kamala Harris appears to have only one healthcare policy – impose price controls. The untenable financial position of many doctors and private doctor practices due to tightening Medicare reimbursement rates exemplifies the folly of her preferred approach. As I document in a recent ...
Commentary
Learn how Vance's suggestion would benefit consumers
Vance’s Argument on Preexisting Conditions a Sure Winner
When asked how people with pre-existing conditions would fare under a Trump-Vance administration during last week’s vice-presidential debate, Sen. J.D. Vance, R-Ohio, was unequivocal. “Well, of course, we’re going to cover Americans with pre-existing conditions.” The question was prompted by Vance’s statement last month that the Republican ticket would consider creating different risk ...
340B. drug pricing
How The Hospital Industrial Complex Robs Poor Patients
Pharmaceutical leader Johnson & Johnson recently unleashed a firestorm in Washington after it proposed a change to how it offers discounted prices on two drugs in a little-known, but enormous, federal program that’s hurting the low-income patients it was created to help. That program, known as the “340B Drug Pricing Program,” allows ...
Commentary
Harris’s Farcical Price Control Schemes
Karl Marx famously said that history repeats itself first as tragedy, then as farce. Vice President Kamala Harris is bringing that aphorism to life by putting price controls at the center of her economic agenda. Despite centuries of evidence that such controls invariably lead to shortages, rationing and general economic ...
Learn more about how government intervention is harming the healthcare market
Trump vs. Harris on Health Care: Experts Explain Each Side
“He and his colleagues believe that patients are not in control of the health care system and that we suffer from an opaque and complex pricing structure that harms patients. “Winegarden’s free market approach means he advocates for doing away with the Obamacare subsidies that Congress must consider, as they ...
Learn more about how price controls hurt patients
Harris’s Home Care Promises Unworkable, Unwise
U.S. Vice President Kamala Harris’s new proposal to provide subsidized at-home care for seniors through Medicare has received a warm reception from many academics and advocates for the elderly. But the likely cost of this new plan — not just to taxpayers but to the health of patients both present and future ...
Learn more about escalating healthcare costs
Medicare should not cover at-home care
Vice President Kamala Harris announced a plan earlier this month to add home healthcare benefits to Medicare. The plan is a fiscal fantasy. Medicare is already in a fiscal crisis, and new benefits will only make things worse. According to the Brookings Institution, covering seniors’ home care for even one year would cost Medicare $40 billion. The program ...
Learn more about health care reform
What Trump’s health care plan could look like
Former President Donald Trump has been jeered for saying he has “concepts of a plan” for repealing and replacing Obamacare. But that’s not quite fair. Trump’s first term in office suggests that he favors market-based reforms that increase patients’ choices. With just under a month until the election, it’s time ...
Learn more about how price fixing stifles innovation
New Schizophrenia Drug Represents Promise Of Pharmaceutical Innovation
Late last month, the U.S. Food and Drug Administration approved Bristol Myers Squibb’s KarXT, a treatment for schizophrenia. The drug, which will be marketed under the brand name Cobenfy, is promising not just because it is effective at treating the debilitating mental health condition. It also seems not to have the potentially harmful side ...
Learn more about healthcare reform
Vance’s Critics Wrong: No Need to Fear High-Risk Pools
Following the recent vice-presidential debate, Sen. J.D. Vance, R-Ohio, continues to face attacks on his ideas for covering people with pre-existing conditions. Vance’s critics call his proposal — which would separate out sicker patients into a separate high-risk insurance pool — inhumane and impractical. As Arthur Caplan, the head of medical ethics at NYU ...
Learn more about how price controls are driving physician shortages
Price Controls Are Harming Doctors
Whether its pharmaceuticals or health insurance, Vice President Kamala Harris appears to have only one healthcare policy – impose price controls. The untenable financial position of many doctors and private doctor practices due to tightening Medicare reimbursement rates exemplifies the folly of her preferred approach. As I document in a recent ...
Learn how Vance's suggestion would benefit consumers
Vance’s Argument on Preexisting Conditions a Sure Winner
When asked how people with pre-existing conditions would fare under a Trump-Vance administration during last week’s vice-presidential debate, Sen. J.D. Vance, R-Ohio, was unequivocal. “Well, of course, we’re going to cover Americans with pre-existing conditions.” The question was prompted by Vance’s statement last month that the Republican ticket would consider creating different risk ...
How The Hospital Industrial Complex Robs Poor Patients
Pharmaceutical leader Johnson & Johnson recently unleashed a firestorm in Washington after it proposed a change to how it offers discounted prices on two drugs in a little-known, but enormous, federal program that’s hurting the low-income patients it was created to help. That program, known as the “340B Drug Pricing Program,” allows ...
Harris’s Farcical Price Control Schemes
Karl Marx famously said that history repeats itself first as tragedy, then as farce. Vice President Kamala Harris is bringing that aphorism to life by putting price controls at the center of her economic agenda. Despite centuries of evidence that such controls invariably lead to shortages, rationing and general economic ...
